YahooOctober 20, 2026 at 9:12 AM NY7 Days Ago
Can This Small Biotech Enter A $4.3 Billion AbbVie Market? Rapport Shoots Higher
Rapport Therapeutics stock shot higher Tuesday on promising, but mixed, test results for its bipolar treatment.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
